patent/CY-1113039-T1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1113039-T1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-22
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C17-16
filingDate	2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_776cc55209921069daf8e4c8ce481ff5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_854814d362788f9f1f531b3cec4e8c36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07a691965dbbf09af93f80a97787406e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1838f890ce116628719fc63115094ff7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dedd195925d4f310c285ffab2f0a62af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fafb5c3a0a47ae2a6d4788af68566612 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6ae6e5c4f519a8d991306159c9ecfec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94f4814ef02d5431a14c211071834e2
publicationDate	2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CY-1113039-T1
titleOfInvention	ELECTRIC AND MALONIC TRANS-4- (1R, 3S) -6-CHLORO-3-FINYLINDAN-1-Yl) -1,2,2-TRIMETHYLPIPERAZINE AND USE FOR MEDICINE
abstract	4- (1R, 3S) -6-Chloro-3-phenylindan-1-yl) -1,2,2-trimethylpiperazine acidic acid or malonic acid, pharmaceutical compositions containing these salts and their medical use, including the treatment of schizophrenia and other psychiatric disorders. Also described are methods for the preparation of 4- (1R, 3S) -6-chloro-3-phenylindan-1-yl) -1,2,2-trimethylpiperazine and its medical uses.
priorityDate	2003-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474255 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID867

Total number of triples: 48.